Suppr超能文献

健康与疾病中的CD4+CD25+调节性T细胞

CD4+CD25+ regulatory T cells in health and disease.

作者信息

Liu Haiying, Leung Bernard P

机构信息

Division of Immunology, Infection and Inflammation, University of Glasgow, Glasgow, UK.

出版信息

Clin Exp Pharmacol Physiol. 2006 May-Jun;33(5-6):519-24. doi: 10.1111/j.1440-1681.2006.04401.x.

Abstract
  1. Over the past 5 years, tremendous progress has been made in understanding the suppressive mechanisms of T regulatory (Treg) cells. The Treg cells, a subpopulation of T cells, have been shown to play an important role in maintaining peripheral tolerance and the prevention of autoimmunity. 2. Various populations of Treg cells have been described, including thymically derived CD4(+)CD25(+) Treg cells. These naturally occurring Treg cells are present in the periphery and are capable of suppressing proliferation and effector T cell responses both in vitro and in vivo. 3. In addition, a second subset of Treg cells, type 1 T regulatoary (Tr1) and Th3 cells, exert their suppressive capacity via cytokines such as interleukin-10 and transforming growth factor-beta and are contact independent. 4. The present review summarizes the characteristics and molecular basis of CD4(+)CD25(+) Treg cells, as well as their therapeutic potential in modulating inflammatory diseases, such as inflammatory bowel disease and rheumatoid arthritis.
摘要
  1. 在过去5年里,在理解调节性T(Treg)细胞的抑制机制方面取得了巨大进展。Treg细胞是T细胞的一个亚群,已被证明在维持外周免疫耐受和预防自身免疫中发挥重要作用。2. 已描述了多种Treg细胞群体,包括胸腺来源的CD4(+)CD25(+) Treg细胞。这些天然存在的Treg细胞存在于外周,能够在体外和体内抑制增殖及效应T细胞反应。3. 此外,Treg细胞的第二个亚群,即1型调节性T(Tr1)细胞和Th3细胞,通过白细胞介素-10和转化生长因子-β等细胞因子发挥其抑制能力,且不依赖细胞接触。4. 本综述总结了CD4(+)CD25(+) Treg细胞的特征和分子基础,以及它们在调节炎症性疾病(如炎症性肠病和类风湿性关节炎)方面的治疗潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验